News & Events
August 21 2018

NICE Approves New Minimally Invasive Steam
Ablation Treatment for Benign Prostatic
Hyperplasia

['NICE Approves New Minimally Invasive Steam\r', 'Ablation Treatment for Benign Prostatic\r', 'Hyperplasia']

Today NICE have announced that Current evidence on the safety and efficacy of transurethral water vapour ablation for urinary tract symptoms caused by benign prostatic hyperplasia is adequate to support the use of this procedure provided that standard arrangements are in place for clinical governance, consent and audit.

NICE has said this procedure works well for lower urinary tract symptoms caused by benign prostatic hyperplasia. There are no serious concerns about its safety. It can be used for people with lower urinary tract symptoms caused by benign prostatic hyperplasia.

Benign prostatic hyperplasia is a non-cancerous enlargement of the prostate. It can block or narrow the urethra (the tube that urine passes through to leave the body), causing problems with passing urine. During this procedure, heated water vapour is injected into the prostate using a probe that is passed up the urethra. The heat from the vapour destroys some of the prostate tissue, reducing its size.

NHS Choices may be a good place to find out more. NICE’s information on
interventional procedures guidance has more about what a procedure is and how NICE assess them.

To find out more click here

Most recent
What is NICE Recommendation and Why is it Useful?
July 10 2020
What is MedTech Market Access?
June 04 2020
Planning Your Engagement Strategy with the NHS Post-Covid-19
June 04 2020
“Battle Stations”: MedTech Can Fight Against Unseen Enemies Like Covid-19
April 02 2020
MedTech Industry Engagement with NHS England after Covid-19
March 20 2020
New NHS England MedTech Funding Mandate Proposal – to get innovative medical devices, diagnostics and digital products to patients faster
November 16 2019
Innovative Approach That Gets Patients Back Into Their Own Homes After Hospital Stay Honoured - NHS England
July 25 2019
Health Technology Evaluation Methods
July 23 2019
NHS England Medical Device Reimbursement Opportunities
July 01 2019
NICE Guidance for High Performing MedTech Products an Accelerated Access Scheme
May 02 2019
IGES Institut GmbH Acquires Majority Shareholding in Device Access UK
March 04 2019
NICE Approves New Minimally Invasive Steam Ablation Treatment for Benign Prostatic Hyperplasia
August 21 2018
Device Access CEO Presenting at NIHR Surgical MedTech Cooperative National Meeting 2018 – Leeds Wednesday 7th November 2018
October 02 2018
Device Access CEO Presenting at 2018 MedTech Reimbursement Roundtable Zurich Tuesday October 30th
October 02 2018
NICE Today recommend iFuse for treating chronic sacroiliac joint pain
October 02 2018
NHS England is Calling on the Best Innovators from Across the World to Apply to Join New NHS Adoption Scheme to Ensure Patients Benefit from New Technology Faster.
September 14 2018
Device Acccess is Attending Medical Alley Innovation Summit October 2nd 2018
September 06 2018
Device Access Attending Advamed Philadelphia 24th-27th September 2018
August 22 2018
Contact us